1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Clinical and characteristics of patient populationa
Radiation NecrosisTumor RecurrenceP Value
Median age (yr) (95% CI)54 (44–63.2)59 (50.9–65.3).34
Female/male13% (1/12)21% (4/15).35
Initial tumor grade: grade 3, grade 40, 134, 15.098
Median duration from radiation treatment to study MR imaging (days), (95% CI)179 (142–462)275 (191–915).066
% Lesions with reresection30% (5/13)68% (13/19).27
Median duration from imaging to reresection (days) (95% CI)2015 (13.5–26).96
Median Karfnosky score (range)80 (75.3–90)80 (70–90).43
  • ↵a Patients with 2 lesions are entered as 2 separate entries for the purpose of this table.